Rajapandiyan Krishnamoorthy

Dr. Rajapandiyan Krishnamoorthy


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2025 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
SJSelvaraj Jayaraman
Selvaraj Jayaraman
MPMonisha Prasad
Monisha Prasad
SNsathan raj Natarajan
sathan raj Natarajan
RKRajapandiyan Krishnamoorthy
Rajapandiyan Krishnamoorthy
MAMohammad A. Alshuniaber
Mohammad A. Alshuniaber
Chella Perumal PalanisamyChella Perumal Palanisamy
Chella Perumal Palanisamy

4 October 2023 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
MPMonisha Prasad
Monisha Prasad
SJSelvaraj Jayaraman
Selvaraj Jayaraman
SNSathan Raj Natarajan
Sathan Raj Natarajan
VVVishnu Priya Veeraraghavan
Vishnu Priya Veeraraghavan
RKRajapandiyan Krishnamoorthy
Rajapandiyan Krishnamoorthy
MEMohamed Elrobh
Mohamed Elrobh

17 May 2023 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SJSelvaraj Jayaraman
Selvaraj Jayaraman
KKkalaiselvi krishnamoorthy
kalaiselvi krishnamoorthy
MPMonisha Prasad
Monisha Prasad
VVVishnu Priya Veeraraghavan
Vishnu Priya Veeraraghavan
RKRajapandiyan Krishnamoorthy
Rajapandiyan Krishnamoorthy
GUGunassekaran
Gunassekaran

1 November 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SNsathan raj Natarajan
sathan raj Natarajan
RKRajapandiyan Krishnamoorthy
Rajapandiyan Krishnamoorthy
MAMohammad A. Alshuniaber
Mohammad A. Alshuniaber
KAKhalid Mashay Alanzi
Khalid Mashay Alanzi
MFMOHAMMAD ABUL FARAH
MOHAMMAD ABUL FARAH
SJSelvaraj Jayaraman
Selvaraj Jayaraman

17 April 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
NMNandagopal Murugan
Nandagopal Murugan
RKRajapandiyan Krishnamoorthy
Rajapandiyan Krishnamoorthy
JKJaved Masood Khan
Javed Masood Khan
MGMansour K. Gatasheh
Mansour K. Gatasheh
JMJambulingam Malathi
Jambulingam Malathi
SJSelvaraj Jayaraman
Selvaraj Jayaraman

30 June 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
RARasheed Abdulraheem
Rasheed Abdulraheem
RMRalph Martins
Ralph Martins
RKRajapandiyan Krishnamoorthy
Rajapandiyan Krishnamoorthy
MAMohammad A. Alshuniaber
Mohammad A. Alshuniaber
Prashant BharadwajPrashant Bharadwaj
Prashant Bharadwaj
BFBinosha Fernando
Binosha Fernando
Background/Objective: Accumulation of amyloid-beta (Aβ) senile plaques in the human brain is a major hallmark of Alzheimer’s disease (AD), which manifests as progressive decline in memory and cognitive functions and currently lacks effective disease-modifying therapies. Emerging evidence demonstrates that polyphenol-rich plant foods are potential complementary therapies for AD. Methods: In this study, we investigated crude polyphenol extracts (CPEs) and purified polyphenol extracts (PPEs) from three sorghum genotypes for their ability to inhibit Aβ42-induced toxicity in MC-65 cells. Thioflavin T fluorescence, cell viability, mitochondrial function, oxidative stress assays, and Western blotting, along with RNA sequencing and computational analyses, were used to characterise both functional and transcriptomic responses of the cells to polyphenol treatments. Results: CPEs and PPEs inhibited Aβ42 aggregation by 67–76% and significantly reduced Aβ oligomer species. The extracts increased cell viability against Aβ-induced toxicity by more than 70%, decreased intracellular oxidative stress, and enhanced mitochondrial activity by over 80%. Transcriptomic profiling revealed differential modulation of genes associated with ferroptosis and MAPK/NF- κB signalling pathways, indicating regulation of inflammatory and oxidative-stress responses are mechanisms underlying the observed neuroprotection. Conclusions: This study demonstrates that polyphenol extracts from black and red sorghum genotypes exert strong multitarget neuroprotection against Aβ42 toxicity in MC-65 cells. These findings support further evaluation of sorghum-derived polyphenols as complementary therapeutic candidates for AD, with in vivo studies required to establish efficacy and translational potential.